Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2114379
Max Phase: Preclinical
Molecular Formula: C35H39Cl2N3O6
Molecular Weight: 668.62
Molecule Type: Small molecule
Associated Items:
ID: ALA2114379
Max Phase: Preclinical
Molecular Formula: C35H39Cl2N3O6
Molecular Weight: 668.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N1CC[C@@H](Oc2ccc(Cl)cc2Cl)C[C@@H]1C(=O)O
Standard InChI: InChI=1S/C35H39Cl2N3O6/c1-35(17-23-18-38-28-5-3-2-4-26(23)28,39-34(44)46-31-21-11-19-10-20(13-21)14-22(31)12-19)33(43)40-9-8-25(16-29(40)32(41)42)45-30-7-6-24(36)15-27(30)37/h2-7,15,18-22,25,29,31,38H,8-14,16-17H2,1H3,(H,39,44)(H,41,42)/t19?,20?,21?,22?,25-,29-,31?,35+/m1/s1
Standard InChI Key: IDKSGHOHJZZRDZ-XNYGLBMGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 668.62 | Molecular Weight (Monoisotopic): 667.2216 | AlogP: 6.85 | #Rotatable Bonds: 8 |
Polar Surface Area: 120.96 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.79 | CX Basic pKa: | CX LogP: 6.41 | CX LogD: 3.15 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.24 | Np Likeness Score: -0.25 |
1. Bellier B, Da Nascimento S, Meudal H, Gincel E, Roques BP, Garbay C.. (1998) Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid., 8 (11): [PMID:9871777] [10.1016/s0960-894x(98)00231-5] |
Source(1):